학술논문

IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity
Document Type
Article
Source
In: Genes and Cancer. (Genes and Cancer, 2015, 5(1-2):41-55)
Subject
Language
English
ISSN
19476027
19476019